S

Sacheerome Ltd

Q2 FY27Chemicals & Petrochemicals

Sacheerome Q2 Results 2026 (FY27): Guides 20–40% Revenue Growth, Steady Margins

Q2 FY27 earnings call: what management said on revenue, margins and capex.

What the Q2 FY27 call signalled

4 of 5 strong

RevenueGood growth
MarginMargins steady
CapexCapex planned
FundraiseFundraise planned
Order bookOrder book rising
Price₹390
Market cap₹873 Cr
P/E28.8

The short version

Sacheerome Limited sees significant growth potential as the market is still largely untapped ("not even at the tip of the iceberg"). Management expects steady financial growth supported by the new YEIDA facility, which began trial production in September 2026 and is ready for commercial production.

From Sacheerome Ltd's Q2 FY27 earnings-call transcript · updated 7 Nov 2026.

How did Sacheerome's revenue grow in the September 2026 quarter?

Good growth
  • Sacheerome Limited sees significant growth potential as the market is still largely untapped ("not even at the tip of the iceberg").
  • New YEIDA facility will enable large-scale production expansion and support growth (targeting INR 300 crores revenue by FY29).
  • The company is working at 20-28% above current capacity and under pressure from customers, indicating strong demand.
  • Plans to ramp up new facility utilization quickly, aiming for full capacity utilization soon.
  • Growth driven by increasing product launches from clients, including big FMCG and newer beauty brands in India.
  • Continued innovation, new products, and adherence to regulatory changes cited as growth enablers.

2 more points from Sacheerome Ltd's call on revenue

Create a free account to keep reading this call

What happened to Sacheerome's margins in Q2 FY27?

See what Sacheerome Ltd said on profitability & margins — free account, 30 seconds.

What capex is Sacheerome planning?

Capex planned
  • Sacheerome Limited has made significant capital expenditure on their new YEIDA facility, with a total planned capex of approximately INR 180-184 crores.
  • As of September 30, 2026, around INR 110 crores had been incurred on this project, funded through IPO proceeds and internal accruals.
  • The new YEIDA production facility is ready and trial productions are ongoing, with commercial production set to commence soon.
  • Additional investments are planned for supporting long-term capacity expansion, including setting up global R&D centers, evaluation centers, and quality centers.

2 more points from Sacheerome Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Is Sacheerome raising money or cutting debt?

See what Sacheerome Ltd said on fundraising & capital structure — free account, 30 seconds.

How big is Sacheerome's order book?

Order book rising
  • The YEIDA facility is ready to produce as per demand and new product launches.
  • The company is currently operating at 20% above existing capacity, indicating strong order pressure.
  • There is consistent incoming demand from existing customers, supported by confirmed orders, but exact utilization percentages are hard to quantify.
  • Orders are sticky due to the specialized nature of the fragrance and flavors industry, with long-term customer relationships.
  • Management sees a very high pressure for ramp-up and expects to bring the new facility to optimum utilization level soon.

2 more points from Sacheerome Ltd's call on order book

Create a free account to keep reading this call

More Q2 FY27 results in Chemicals & Petrochemicals

All Q2 FY27 results | Chemicals & Petrochemicals rankings

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Sacheerome Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Sacheerome Ltd Q2 FY27 results?

Sacheerome Limited sees significant growth potential as the market is still largely untapped ("not even at the tip of the iceberg"). Management expects steady financial growth supported by the new YEIDA facility, which began trial production in September 2026 and is ready for commercial production.

What is Sacheerome Ltd share price analysis?

Sacheerome Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 28.8 with a market cap of ₹873 Cr. Investors should review the full earnings analysis for detailed insights.

Is Sacheerome Ltd planning capital expenditure?

Sacheerome Limited has made significant capital expenditure on their new YEIDA facility, with a total planned capex of approximately INR 180-184 crores.

Keep Sacheerome Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.